MMedication Read More GLP-1 drugs reshape alcohol consumption and hospitality habitsApril 2, 2026 Millions of Britons using GLP-1 weight loss medications are beginning to alter how they drink, dine and choose…
MMedication Read More All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weightApril 2, 2026 G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
MMedication Read More Large GLP-1 Drug Review Takes Closer Look at Risks, RewardsApril 2, 2026 Moderate- to high-quality evidence from an umbrella review on non-cardiometabolic outcomes reinforced links between GLP-1 therapies and risks…
MMedication Read More FDA Approves Eli Lilly’s GLP-1 PillApril 1, 2026 The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily,…
MMedication Read More DC dietician raises concerns over compounded GLP-1 weight-loss medicationsMarch 31, 2026 As GLP-1 medications grow in popularity not just for treating diabetes but also for weight loss, some people…
NNutrition Read More Creatine Brand Create Wellness Raises $20 Million In Fresh FundingMarch 31, 2026 Create Wellness launched on Monday a Creatine + Electrolyte mix that will be available on Create’s website, Amazon,…
MMedication Read More Jacksonville research group exploring new paths to lasting weight loss beyond GLP-1 drugsMarch 26, 2026 JACKSONVILLE, Fla. – For some, GLP-1 drugs feel like a weight-loss miracle. For others, the weight comes right…
MMedication Read More ‘Substantial’ increase in fake or illegal weight-loss drugs seized by HPRA last yearMarch 26, 2026 We need your help now Support from readers like you keeps The Journal open. You are visiting us…
MMedication Read More FDA approves new ‘Wegovy HD’ with triple the dosage of the semaglutide medicationMarch 25, 2026 The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.…
MMedication Read More Ozempic is getting generics as low as $15 — what it means for AmericansMarch 19, 2026 The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
MMedication Read More Is the ‘Ozempic era’ an opportunity for no-and-low?March 18, 2026 With growing research to suggest GLP-1 drugs reduce the desire to drink alcohol, Eloise Feilden asks whether the…
MMedication Read More What to Know about the Experimental GLP-1 Drug CagriSemaMarch 18, 2026 3 min read THESE DAYS, WHEN it comes to weight loss drugs, you’ve got a veritable buffet of…